Tentt

CrossBridge Bio Acquired by Eli Lilly | Healthcare M&A Deal

Announced
HealthcareTexasAdd-on

Deal Overview

Eli Lilly has acquired CrossBridge Bio, a medical devices business in Texas, for up to $300 million. CrossBridge Bio is an innovative healthcare company backed by CE-Ventures, with an initial $10 million financing round in 2024 that supported its biotechnology development. Eli Lilly acquisitions in medical devices acquisition expand its healthcare M&A footprint in TX acquisitions by adding CrossBridge Bio’s technology and product pipeline. The CrossBridge Bio acquisition is structured as an add on acquisition and strategic acquisition under CE-Ventures’ corporate venture capital platform, with deal terms reported as up to $300 million and an announced status.

Key Details

Transaction
Eli Lilly acquires CrossBridge Bio
Deal Size
Over $100M
Reported Value
$13

Filed under

Source

Read full article on zawya.com

via GN - portfolio company acquisition · April 14, 2026

Powered by Tentt

Source healthcare deals in Texas for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals